• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Intel & Sheba Partner to Develop AI Solution to Improve Detection of Crohn’s Disease

Share:

August 1, 2022

What You Should Know:

– Sheba Medical Centre, Israel’s largest medical center, today announced a collaboration with Intel Corporation to help doctors improve the diagnosis and treatment of people with Crohn’s disease.

– Sheba developed a new, first-of-its-kind application capable of quickly and accurately analyzing extensive video data of a patient’s digestive system, providing valuable insights to aid medical professionals.

AI-driven Solutions to Diagnose Crohn’s Disease

The solution’s artificial intelligence-based algorithm, powered by Intel hardware and software technologies, aids clinicians in the identification of Crohn’s symptoms such as inflammation and ulcers, helping to assist in early prediction of disease severity in order to identify treatment needs. Not only will this predictive capability help medical teams provide optimal and personalized care for millions of Crohn’s patients worldwide, it can help lower the risks of severe medical complications, hospitalization, and invasive surgical procedures for these patients. This is the first app that analyzes capsule videos from the digestive system of patients, and by presenting meaningful information to the doctors, helping them to recommend better treatment for the patient.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Following a recent joint research that enrolled as capsule videos of 101 new Crohn’s patients at Sheba, an algorithm was developed to predict the need for biological treatment. AI algorithm was the most accurate diagnostic tool, with 86% accuracy in prediction of treatment decisions compared to 70% accuracy achieved by manual reading by capsule endoscopy expert or 74% accuracy of the most accurate stool biomarker (fecal calprotectin).

“Accelerate, Redesign and Collaborate (ARC) focuses on advanced technologies with the goal to make impact on medicine in Israel and globally through digital health solutions,” said Dr. Eyal Klang, Head of the Sami Sagol AI (Artificial Intelligence) Hub at the ARC Innovation Center. “This collaboration with Intel exceeded expectations and is further proof of the contribution of artificial intelligence to the medical field. Over the next decade we will see more and more advanced algorithms entering hospitals and supporting doctors’ work.”

Strategic Vision

The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation. Sheba’s City of Health boasts an acute-care hospital, rehabilitation hospital, research and innovation hubs, medical simulation center, as well as a center for disaster response on one comprehensive campus in the heart of Israel. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Population Health Company Color Health Acquires Mental Health Platform Mood LiftersPopulation Health Company Color Health Acquires Mental Health Platform Mood Lifters
  • BrightSpring and PharMerica combine to form comprehensive health services companyBrightSpring and PharMerica combine to form comprehensive health services company
  • Orbita and US hospital explore how voice of AI can improve careOrbita and US hospital explore how voice of AI can improve care
  • Paradigm launches with $203M funding round to expand clinical trial accessParadigm launches with $203M funding round to expand clinical trial access
  • Dariohealth Partners with Mediorbis to Bring Telemedicine to Its Mobile Disease Management PlatformDariohealth Partners with Mediorbis to Bring Telemedicine to Its Mobile Disease Management Platform
  • SP Acquires Spain Based i-DositecnoSP Acquires Spain Based i-Dositecno
  • Evive Acquires Treatment-Guidance Tool WiserTogetherEvive Acquires Treatment-Guidance Tool WiserTogether
  • BiointelliSense Acquires AlertWatch to Expand Its Patient Monitoring ProductsBiointelliSense Acquires AlertWatch to Expand Its Patient Monitoring Products

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications